Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UltraEZ Desensitizing Agent With In-Office Bleaching
NCT07355647Phase 1Completed
- Sponsor
- Universidad de Santiago de Compostela
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial in dentin hypersensitivity (DH) comparing UltraEZ Group with Placebo Group (2 arms). Primary endpoint: Questionnaire of dental sensitivity. Started May 2025; status: completed.
02
Drugs
UltraEZ
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT07355647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07355647.